Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05825027 · ClinicalTrials.gov registry record
Risk Stratification in Children With Concussion
A clinical trial of Mild Traumatic Brain Injury and Concussion, Brain, sponsored by Duke University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05825027: Recruiting study of Mild Traumatic Brain Injury and Concussion, Brain, sponsored by Duke University.
NCT05825027 is a study of Mild Traumatic Brain Injury and Concussion, Brain that is actively recruiting participants, run by Duke University. The registered enrollment target is 500 participants, above the 209-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (139% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05825027, a study of Mild Traumatic Brain Injury and Concussion, Brain, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will measure concussion symptoms, biological markers, and academic and social factors across the first year postconcussion to develop a model that enables early identification of and symptom management for children at higher risk for persistent postconcussive symptoms. Findings will provide novel insights into the longer-term effects of concussion on children's physical, psychological, and social well-being and support the development of personalized healthcare and school-based plans to reduce disparities in children's ability to return-to-learn and -play and improve postconcussion quality of life.
Primary Outcome
The PCSS consists of 22 questions that relate to post-concussive symptoms. Survey-takers are asked to rate each symptom according to a 7-point Likert scale ranging from 0-6. Higher scores indicate a higher severity of post-concussive symptoms. The greatest possible score is 132 and the lowest possible score is 0.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Health System - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2028-02-28 |
What NCT05825027 shows while recruiting
NCT05825027 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 209-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (139% higher).
The record links to 2 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT05825027 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05825027 about?
NCT05825027 is a clinical study titled "Risk Stratification in Children With Concussion". This project will measure concussion symptoms, biological markers, and academic and social factors across the first year postconcussion to develop a model that enables early identification of and symptom management for children at higher risk for persistent postconcussive symptoms. Findings will pro...
What is the current status of trial NCT05825027?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-05-23. Estimated completion is 2028-02-28.
What conditions does trial NCT05825027 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Concussion, Brain.
Who is sponsoring clinical trial NCT05825027?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05825027 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05825027's enrollment target sits among peer trials
500 4th of 43 higher than 40 of 43 other Mild Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
-
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
RECRUITING · NA
-
Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI